亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

賴諾普利 83915-83-7

 
 
單價 面議對比
詢價 暫無
發貨 山東濟南市付款后3天內
型號 83915-83-7
過期 長期有效
更新 2013-03-07 16:54
 

濟南偉都化工科技有限公司

企業會員第13年
資料未認證
保證金未繳納
詳細說明

"賴諾普利 83915-83-7

CAS 83915-83-7
英文:Lisinopril
別名 1-[N2-((S)- 羰基 )-3- 苯丙基]-L- 賴氨酰基-L- 脯氨酸
分子式 C21H31N3O5·2H2O FW 414.5
外觀 白色結晶性粉末
質量標準 符合 USP26,27,EP2011
產品用途 抗高血壓藥物
包裝 1kg/ 聽,5kg/ 聽,25kg/ 桶
貯藏 遮光,密封保存 "
"Lisinopril

CAS 83915-83-7
Name (s)-1-(n2-(1-carboxy-3-phenylpropyl)-l-lysyl)-l-proline dihydrate
Molecular formula C21H31N3O5·2H2O FW 414.5
Appearance white crystalline powder
Quality standard USP29,31 , EP5.0
Uses antihypertensive
Packing 1kg/can, 5kg/can, 25kg/drum
Storage Sealed, in dark place
"
舉報收藏 0評論 0
更多>本企業其它產品
西他列汀 486460-32-6 磷酸西他列汀 654671-78-0 利伐沙班 366789-02-8 82586-55-8 83915-83-7 98048-97-6 88889-14-9
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |